Paul Daruwala - 30 Sep 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Chief Operating Officer
Signature
/s/ Paul Daruwala
Issuer symbol
CDTX
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
4
Filing time
04 Oct 2021, 21:27:26 UTC
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Award $0 +132,000 +261% $0.000000 182,531 30 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.